Kissei Pharmaceutical Co., Ltd: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial ReportiCD ResearchFebruary 2, 2012 31 Pages - SKU: ICDR6792216 |
| Synopsis ICD Research's Kissei Pharmaceutical Co., Ltd: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries. Summary ICD Research's Kissei Pharmaceutical Co., Ltd: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report is a crucial resource for industry executives and anyone looking to access key information about Kissei Pharmaceutical Co., Ltd.. ICD Research's Kissei Pharmaceutical Co., Ltd: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
Kissei Pharmaceutical Co., Ltd. (Kissei) is focused on discovery, manufacture and sale of pharmaceutical products; based in Japan. The company together with its subsidiaries operates two industrial divisions: Pharmaceutical and Other. The company's offices are located at various locations across Japan that includes: Matsumoto, Tokyo, Azumino, Joetsu, and Shiojiri. The company has six subsidiaries which include three consolidated subsidiaries and three non-consolidated subsidiaries. Apart from Japan, the company has presence in the US, the UK and other overseas countries. The manufacturing plants of Kissei are situated at Matsumoto city and Shiorjiri city in Japan. Kissei is headquartered in Matsumoto, Japan. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

